ESMO Sarcoma and Rare Cancers Congress 2027

The ESMO Sarcoma and Rare Cancers Congress 2027 brings together clinicians, researchers, healthcare professionals, industry partners and patient advocates from the international rare cancers community to advance research and care for rare solid tumours, including sarcomas.

The programme focuses on sarcomas and other rare cancers across organ sites, including molecular diagnostics, emerging therapies such as antibody–drug conjugates and KRAS-targeted treatments, and access to new therapies in public healthcare systems.

Through educational sessions, special sessions, a Multidisciplinary Tumour Board and abstract presentations, participants can review recent evidence, consider its relevance to patient care and exchange experience with experts and peers.

Special sessions on international collaborative research bring together research networks from Europe, Asia, Australia and North America, and Young Oncologists sessions on each day of the congress encourage learning and interactive dialogue.
Over three days in Lugano, the congress offers a setting to share experience and strengthen the collaborations that support patients with sarcomas and rare cancers worldwide.